Drug Database
CA

calcium carbonate + vitamin D3 (Ideos)

✓ Approved

Innothera · VDR · Small Molecule

What is calcium carbonate + vitamin D3?

calcium carbonate + vitamin D3 is a small molecule developed by Innothera. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesIdeos
CompanyInnothera
Drug ClassSmall Molecule
Molecular TargetVDR
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

calcium carbonate + vitamin D3 acts on 1 molecular target:

VDRvitamin D receptor (NR1I1, PPP1R163)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

calcium carbonate + vitamin D3 is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Musculoskeletal and connective tissue disordersOsteoporosis✓ Approved

Related Research Articles

PubMedOpen life sciences2026-09-20

Comparative analysis of vitamin C derivatives on ATP homeostasis across diverse cell types.

Goc Anna A, Sumera Waldemar W, Niedzwiecki Aleksandra A

Cellular energy homeostasis is tightly regulated by mitochondrial function and substrate availability. Vitamin C is a redox-active molecule with emerging roles in cellular metabolism; however, the metabolic impacts of structurally distinct vitamin C derivatives remain incompletely defined. In this study, we systematically compared l-ascorbic acid, dehydroascorbic acid, 6-O-palmitoyl-l-ascorbate, and mineral ascorbates (calcium, magnesium, sodium, and potassium salts) across multiple mammalian cell types. Cells were exposed to concentrations ranging from 60 to 500 µM, encompassing physiologically and pharmacologically relevant levels. The vitamin C derivatives induced cell type- and concentration-dependent modulation of intracellular ATP levels. Notably, HepG2 and renal epithelial cells exhibited robust ATP increases, whereas fibroblasts, myocytes, microglia, and skeletal muscle models displayed variable responses depending on the derivative and dose. Moreover, in skeletal muscle cells, co-treatment of standard l-ascorbic acid with select fatty acids did not yield additive bioenergetic effects, suggesting a localized, substrate-specific plateau or shared regulatory step in this specific cell model. Exposure to l-ascorbic acid induced selective increases in COX-1 without changes in SDH-A, consistent with rapid functional modulation of mitochondrial activity in myocytes and microglial cells only. Collectively, these findings demonstrate that vitamin C derivatives modulate cellular ATP levels within existing metabolic networks in a context-dependent manner, consistent with the modulation of mitochondrial-associated energy metabolism.

PubMedJournal of multidisciplinary healthcare2026-09-20

Association Between SNAIL1 Gene Expression, SNAIL1 Genetic Variation, Vitamin D Receptor Gene Expression, and Vitamin-D Status Among Jordanian Asthmatic Patients.

Zatar Alaa M AM, Jarrar Yazun B YB, Hindash Zain K ZK, Albtoosh Asma S AS et al.

Asthma is a chronic inflammatory airway disease influenced by genetic and environmental factors. Low vitamin-D status has been implicated in asthma severity, while polymorphisms in the SNAIL1 gene, a transcription factor involved in epithelial-mesenchymal transition, may affect airway remodeling. This exploratory study aimed to investigate the relationship between SNAIL1 genetic variants, SNAIL1 and vitamin-D receptor (VDR) gene expression, and vitamin-D status among Jordanian patients with asthma. A case-control study was conducted involving 100 participants classified into four groups according to asthma status and vitamin-D status. Serum vitamin-D levels were measured, and SNAIL1 and VDR gene expression levels were analyzed using quantitative real-time PCR. Relative gene expression was calculated using the 2^-ΔΔCt method. SNAIL1 genetic variants were identified using PCR amplification followed by Sanger sequencing of the SNAIL1 coding exons. Serum vitamin-D concentrations differed significantly among the study groups (p < 0.0001). SNAIL1 expression showed higher fold changes in asthmatic participants than in non-asthmatic participants, irrespective of vitamin D status; however, these differences did not reach statistical significance (p = 0.08-0.09). VDR expression demonstrated a decreasing trend in participants with low vitamin-D status, although most comparisons were not statistically significant. A novel missense variant in SNAIL1 (c.196C>T; p.Ala66Val) was identified in a single asthmatic participant with low vitamin-D status. This participant also exhibited higher SNAIL1 expression; however, the biological significance of this observation remains exploratory. In silico prediction tools classified this variant as benign, and its potential biological significance remains exploratory. This study provides exploratory evidence suggesting potential relationships among SNAIL1 expression, VDR expression, vitamin D status, and asthma in a Jordanian population. The identified SNAIL1 variant represents a preliminary finding requiring further investigation. Larger studies with functional validation are needed to confirm these observations and provide a basis for future multidisciplinary research.

PubMedDiagnosis (Berlin, Germany)2026-09-20

Evaluation of a new non-competitive chemiluminescent immunoassay for 25-OH vitamin D measurement.

Zhong Jinqing J, Huang Binning B, Lin Aihua A, Wu Geng G et al.

The increasing demand for vitamin D measurement over the past few decades has prompted manufacturers to develop automated chemiluminescence immunoassay (CLIA), including the noncompetitive anti-immune complex assay (NACA) system for the measurement of small molecules. This study aims to evaluate the performance of the Snibe-NACA 25-OH Vitamin D assay for measuring total 25-Hydroxy Vitamin D assay [25(OH)D] levels. A total of 200 serum samples were collected from a clinical laboratory for 25(OH)D assay to evaluate the performance of the Snibe-NACA 25-OH Vitamin D assay using a double-blind method. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used as a reference method and the results were compared with those obtained from four other chemiluminescence competitive 25(OH)D assays. The Snibe-NACA 25-OH Vitamin D assay demonstrated satisfactory analytical performance with optimal precision (repeatability CV: 1.13-2.75 %;intra-laboratory CV: 1.59-2.58 %) and relatively small bias (-3.84 % mean relative bias compared with the LC-MS/MS),excellent agreement with LC-MS/MS, as evidenced by Passing-Bablok regression (R2: 0.9245, slope: 0.99, 95 % CI: 0.96-1.03; intercept: -1.24, 95 % CI: -3.49 to 0.65) and high correlation (Spearman's ρ=0.969; ICC=0.9584). Notably, the assay showed the highest concordance with LC-MS/MS in the classification of vitamin D status, achieving an overall agreement of 87.0 %, with particularly strong concordance in identifying deficiency (97.8 %). The Snibe-NACA 25-OH Vitamin D assay demonstrated good performance and compared favorably with both LC-MS/MS and other competitive assays, providing evidence of its high reliability in clinical diagnostic practice.

PubMedCureus2026-09-20

Noncanonical Splice Site Disruption: +4 Intronic Variant in Phosphate-Regulating Endopeptidase Homolog, X-linked (PHEX Gene) Supported by In Silico Analysis in X-linked Hypophosphatemic Rickets.

Panqueba Arias Carlos F CF, Rojas Rodriguez Ingry K IK, Quero Rossi I RI, Baez Cielo C CC

X-linked hypophosphatemic rickets (XLH) is the most common inherited cause of renal phosphate wasting. It is typically caused by pathogenic variants in the phosphate-regulating endopeptidase homolog, X-linked (PHEX gene), which lead to increased levels of fibroblast growth factor 23 (FGF23). However, noncanonical intronic variants represent a significant diagnostic challenge, as they may not be detected by conventional genetic studies and require interpretation supported by bioinformatic tools. We present the case of a pediatric patient with postnatal short stature and progressive genu varum. Biochemical studies revealed hypophosphatemia with reduced tubular reabsorption of phosphate, while calcium, parathyroid hormone (PTH), and vitamin D levels were within normal ranges. Radiological findings were consistent with rickets. Initial clinical exome sequencing was negative. Subsequently, a targeted gene panel identified a previously unreported intronic variant in the PHEX gene (c.1768+4dup; chrX:22,219,105 T>TA). In silico analysis using SpliceAI demonstrated a high probability of donor splice site loss (DS_DL = 0.80), while Pangolin predicted a splice-disrupting effect (score = 0.72); collectively, these findings support a deleterious effect on mRNA splicing. This case highlights the importance of integrating clinical, biochemical, genetic, and computational data for the interpretation of noncanonical intronic variants, expanding the mutational spectrum described for PHEX in XLH.

PubMedSystematic reviews2026-09-20

Bioconversion of β-carotene to vitamin A across life stages using stable isotope methodologies: a protocol for the systematic review.

Frane Ruby D RD, Lat Hazel T HT, Semilla Joanne Jette L JJL, Diaz Joey Mark S JMS et al.

Vitamin A deficiency (VAD) remains a persistent health concern in the Philippines. Studies using stable isotope methods for assessing β-carotene bioconversion to vitamin A in the vulnerable Filipino population are limited. This review protocol aims to map the global evidence in quantifying β-carotene bioconversion efficiency across diverse population age groups and settings. Following the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015, studies published in English between 1 January 2013 and 31 January 2026 will be systematically searched. The databases to be queried include Embase, Web of Science, Scopus, ProQuest, and CINAHL, MEDLINE, and Academic Search Ultimate via the EBSCOhost platform. Citation tracking will also be conducted to identify additional relevant studies. A team of reviewers will conduct a database search, screening, extraction, and procedural analysis. Deduplication will be done using Covidence® software. At least two independent reviewers will perform these tasks. A different reviewer will resolve any conflicts between them. Inclusion criteria are as follows: (a) human participants-apparently healthy or nutritionally at-risk populations, any age group and setting; (b) reporting the use of stable isotope techniques; (c) studies that compare various methodological protocols that use stable isotope techniques and examine the variability of factors across different life stages. Findings will be narratively synthesized in accordance with the Synthesis Without Meta-analysis guidelines, and a descriptive summary will be provided. This review focuses on quantifying β-carotene bioconversion efficiency using stable isotopes in diverse populations. The results aim to guide the selection of suitable isotopic methods for assessing intestinal β-carotene bioconversion efficiency in vulnerable populations. This is particularly relevant in resource-limited settings such as the Philippines. Potential limitations of this review as the research team operating within a developing country context include restriction to English-language publications. Also, the anticipated heterogeneity in study designs, isotope methodologies, and outcome measures may limit direct comparability of findings. Nonetheless, the structured synthesis approach is intended to provide a transparent and rigorous overview of the current evidence base and identify priorities for future research. PROSPERO CRD420261279500.

PubMedOdontology2026-09-20

LL-37-based oral antimicrobial therapeutics: translational challenges and future directions-a narrative review.

J Muruganandhan M, Veeraraghavan Vishnu Priya VP, Govindarajan Sujatha S

LL-37 is an antimicrobial peptide involved in antimicrobial defence, inflammatory regulation, tissue repair, and bone regeneration in the oral cavity. Salivary and gingival crevicular fluid LL-37 levels are associated with disease activity and treatment responses. Although there is solid mechanistic and preclinical data on LL-37, research on clinical applications of this remarkable peptide seem to be stalled due to a multitude of factors. The use of LL-37 in clinical practice is affected by proteolytic degradation, cytotoxicity at higher concentrations, microbial tolerance, biofilm protection, rapid salivary clearance, and high production costs. Our review provides a comprehensive update emphasizing the key gaps in LL-37 research and the translational challenges faced by researchers. We also suggest a three-pronged roadmap to future approaches comprising (i) rational peptide engineering and smart nanocarrier-based delivery, (ii) host-directed induction of endogenous LL-37 via vitamin D and short-chain fatty acid pathways, and (iii) standardisation of salivary/gingival crevicular fluid LL-37 as a non-invasive biomarker, aimed at developing LL-37 as a viable diagnostic and therapeutic agent in periodontal disease, dental caries, endodontic infections, oral mucosal disorders, and oral squamous cell carcinoma. Peptide derivatives, nanocarrier-based delivery systems, combination therapy, and vitamin D-mediated induction are being studied to improve its stability and therapeutic activity. LL-37 may have strong applications in oral diagnosis, prevention, and treatment of oral diseases, if the safety, efficacy, and delivery methods are effectively enhanced.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about calcium carbonate + vitamin D3